Hematopoietic differentiation
Day 0:
To initiate differentiation, prepare a single-cell suspension of iPSCs expanded for 6–7 days on iMatrix-511 in StemFit AK03N using 0.5× TryPLE select
Resuspend a total of 3–6×105 cells in StemFit AK03N supplemented with 10 µM Y-27632 and 10 µM CHIR99021 and seed them in a well of 6-well ultra-low attachment plates
Day 1:
Harvest the EBs, settle them down to the bottom of the tube, remove the supernatant, and resuspend them in 2 ml StemPro-34 supplemented with 10 ng/ml penicillin/streptomycin, 2 mM Glutamax, 50 µg/ml ascorbic acid, 4×10−4 M monothioglycerol and 1× Insulin-Transferrin-Selenium solution (referred to as EB basal medium), 50 ng/ml BMP-4, 50 ng/ml rhVEGF, and 50 ng/ml bFGF per well.
Day 2:
Add 6 µM SB431542 to each well.
Day 4:
Harvest the differentiating EBs as described in day 1 and resuspend them in 2 ml EB basal medium supplemented with 50 ng/ml rhVEGF, 50 ng/ml rhbFGF and 50 ng/ml rhSCF per well.
Day 7:
Harvest the differentiating EBs and resuspend them in 2 ml EB basal medium supplemented with 50 µg/ml rhVEGF, 50 ng/ml rhbFGF, 50 ng/ml rhSCF, 30 ng/ml rhTPO, and 10 ng/ml FLT3L per well.
From days 9-14:
Harvest the differentiating cultures and replace the spent medium with fresh day 7 medium for every 2–3 days.
Cultures should be maintained in a 5% CO2/5% O2/90% N2 environment for the first 7 days and in a 5% CO2 environment from day 7.
T-cell differentiation
Days 13, 20, 27:
Dilute rhDL4/Fc chimera protein solution (10 µg/ml) with an equal volume of Retronectin (10 µg/m) and add 150 µl of the solution to each well of 48-well plates.
Incubate the plate overnight at 4 °C. Remove the coating solution just before adding T-cell differentiation medium.
Day 14:
For iHPC seeding, harvest day 14 EBs and dissociated them into single cell by TryPLE Select treatment, followed by passing through a 21-G needle 7 times. FACS-sort a total of 2000 CD235a−/CD14−/CD34+/CD43+ cells into wells of a DL4-coated plate having T-cell differentiation medium composed of αMEM (Thermo Fisher Scientific) supplemented with 15% FBS (Corning), 100× ITS-G (1×), 55 µM 2-Mercaptoethanol, 50 µg/ml ascorbic acid, 2 mM Glutamax, 50 ng/ml rhSCF, 100 ng/ml rhTPO, 50 ng/ml rhIL-7, 50 ng/ml FLT3L, 30 nM rhSDF-1α (PeproTech), and 15 µM SB203580.
Days 15, 17, 19:
Change a major portion of the medium (80%) every other day.
Day 21:
Transfer the differentiating cells to a new DL4-coated plate
Days 23, 25, 27:
Change a major portion of the medium (80%) every other day.
Day 28:
Transfer a total of 1–2×105 cells/well to a new DL4-coated plate.
Days 30, 32, 34:
Change a major portion of the medium (80%) every other day.
T cell maturation
Day 35:
Stimulate the DL4 cells with a monoclonal antibody to CD3 at the concentration of 500 ng/ml in maturation medium composed of αMEM, 15% FBS, 100× ITS-G (1×), 50 µg/ml ascorbic acid, 100× PSG (1×, Sigma), 10 ng/ml rhIL-7, 10 ng/ml rhIL-2, and 10 nM dexamethasone. Seed 5x105 cells/well of 48-well plate with 1 ml of the maturation medium.
Day 38:
Collect the cells and resuspend them in maturation medium without OKT3 and incubate for 4 days.
T-cell proliferation
Day 41:
On the day before T-cell activation, coat 48-well plates with CD3/Retronectin solution composed of 3.0 µg/ml anti-human CD3 and 150 µg/ml Retronectin at 4 °C overnight.
Day 42:
Resuspend a total of 4×105 iT-cells/ml in T-cell activation medium composed of αMEM supplemented with 15% FBS, 100× ITS-G (1×), 50 µg/ml ascorbic acid, 10 ng/ml rhIL-7, 10 ng/ml rhIL-15, 20 ng/ml rhIL-21, 50 ng/ml rhIL-12, 50 ng/ml rhIL-18, 50 ng/ml rhTL-1A, and 10 µM Z-VAD. Seed the cell suspension to a well of a 48-well plate.
Day 45:
Collect the cultures and resuspend them in proliferation medium composed of aMEM, 15% FBS, 100× ITS-G (1×), 50 µg/ml ascorbic acid, 10 ng/ml rhIL-7, and 10 ng/ml rhIL-15.
Days 47, 49, 51, 53, 55
Change approximately 80% spent medium every 2–3 days, with re-culturing to new wells or larger-culture vessels as needed.